INCREASED PREVALENCE AND ANALYSIS OF RISK FACTORS FOR INDINAVIR NEPHROLITHIASIS
- 1 December 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 164 (6) , 1895-1897
- https://doi.org/10.1016/s0022-5347(05)66911-x
Abstract
Conclusions The clinical prevalence of indinavir nephrolithiasis is much greater than initially reported. Nephrolithiasis during indinavir use does not appear to induce patients to withdraw from the drug.Keywords
This publication has 5 references indexed in Scilit:
- FREQUENCY OF UROLITHIASIS IN INDIVIDUALS SEROPOSITIVE FOR HUMAN IMMUNODEFICIENCY VIRUS TREATED WITH INDINAVIR IS HIGHER THAN PREVIOUSLY ASSUMEDJournal of Urology, 1999
- MANAGEMENT OF INDINAVIR ASSOCIATED NEPHROLITHIASISJournal of Urology, 1997
- Protease Inhibitors and UrolithiasisJournal of Urology, 1997
- Urinary stones in HIV-1-positive patients treated with indinavirThe Lancet, 1997
- NEWSThe Lancet, 1996